tiprankstipranks
Advertisement
Advertisement

ABOS Stock Latest News

Acumen Stockholders Approve Directors and Equity Incentive Plan
Company AnnouncementsAcumen Stockholders Approve Directors and Equity Incentive Plan
1d ago
8K
ABOS
Acumen Pharmaceuticals Warns Investors: Unchanged 10-K Risk Factors Still Weigh on Valuation and Share Price
PremiumCompany Announcements
Acumen Pharmaceuticals Warns Investors: Unchanged 10-K Risk Factors Still Weigh on Valuation and Share Price
22d ago
ABOS
Acumen Pharmaceuticals Bets Big on Alzheimer’s Trials
PremiumCompany Announcements
Acumen Pharmaceuticals Bets Big on Alzheimer’s Trials
23d ago
ABOS
Acumen Updates Q1 Results and Alzheimer’s Pipeline Progress
PremiumCompany Announcements
Acumen Updates Q1 Results and Alzheimer’s Pipeline Progress
24d ago
8K
ABOS
Acumen Pharmaceuticals’ Earnings Call: Promise Amid Pressure
PremiumCompany Announcements
Acumen Pharmaceuticals’ Earnings Call: Promise Amid Pressure
2M ago
ABOS
Acumen files to sell 10.83M shares of common stock for holders
PremiumThe FlyAcumen files to sell 10.83M shares of common stock for holders
2M ago
ABOS
Options Volatility and Implied Earnings Moves Today, March 26, 2026
Premium
Market News
Options Volatility and Implied Earnings Moves Today, March 26, 2026
2M ago
CMC
ABOS
Acumen Updates Alzheimer’s Pipeline, Extends Cash Runway Into 2027
Premium
Company Announcements
Acumen Updates Alzheimer’s Pipeline, Extends Cash Runway Into 2027
2M ago
8K
ABOS
Is ABOS a Buy, Before Earnings?
PremiumPre-Earnings
Is ABOS a Buy, Before Earnings?
2M ago
ABOS
Acumen participates in a conference call with Cantor
PremiumThe Fly
Acumen participates in a conference call with Cantor
2M ago
ABOS
Acumen announces new research findings at Alzheimer’s and Parkinson’s conference
PremiumThe Fly
Acumen announces new research findings at Alzheimer’s and Parkinson’s conference
3M ago
ABOS
Maintaining Buy on Acumen (ABOS): EBD-Enabled Alzheimer’s Pipeline, Extended Runway, and Discounted Valuation Ahead of ALTITUDE-AD Readout
PremiumRatings
Maintaining Buy on Acumen (ABOS): EBD-Enabled Alzheimer’s Pipeline, Extended Runway, and Discounted Valuation Ahead of ALTITUDE-AD Readout
3M ago
ABOS
Acumen Pharma: Differentiated Alzheimer’s Oligomer Antibody and BBB‑Shuttle Platform Support Buy Rating and Higher $8 Target
PremiumRatingsAcumen Pharma: Differentiated Alzheimer’s Oligomer Antibody and BBB‑Shuttle Platform Support Buy Rating and Higher $8 Target
3M ago
ABOS
Acumen price target raised to $8 from $7 at BTIG
Premium
The Fly
Acumen price target raised to $8 from $7 at BTIG
3M ago
ABOS
Acumen Raises Capital to Advance Enhanced Brain Delivery
Premium
Company Announcements
Acumen Raises Capital to Advance Enhanced Brain Delivery
3M ago
8K
ABOS
Acumen announces $35.75M private placement
PremiumThe Fly
Acumen announces $35.75M private placement
3M ago
ABOS
Acumen price target raised to $7 from $4 at BTIG
PremiumThe Fly
Acumen price target raised to $7 from $4 at BTIG
4M ago
ABOS
BIIB
Analysts Predict Up to 400% Spike for These 2 ‘Strong Buy’ Penny Stocks
PremiumStock Analysis & Ideas
Analysts Predict Up to 400% Spike for These 2 ‘Strong Buy’ Penny Stocks
4M ago
ABOS
SABS
Acumen Updates Investor Presentation, Highlights 2026 Alzheimer’s Milestones
PremiumCompany Announcements
Acumen Updates Investor Presentation, Highlights 2026 Alzheimer’s Milestones
5M ago
8K
ABOS
Acumen initiated with a Buy at Lucid Capital
PremiumThe FlyAcumen initiated with a Buy at Lucid Capital
6M ago
ABOS
Acumen announces new research at CTAD on ACU193
Premium
The Fly
Acumen announces new research at CTAD on ACU193
6M ago
ABOS
Acumen price target lowered to $8 from $9 at BofA
Premium
The Fly
Acumen price target lowered to $8 from $9 at BofA
7M ago
ABOS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >